| Dr Georgia Delarosa Cu, MD | |
|
12070 Old Line Ctr, Suite 302, Waldorf, MD 20602-2513 | |
| (301) 645-6667 | |
| (301) 870-9722 |
| Full Name | Dr Georgia Delarosa Cu |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 36 Years |
| Location | 12070 Old Line Ctr, Waldorf, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629127824 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | D0051990 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Privia Care Center Llc | 3274801139 | 192 |
| Privia Medical Group Llc | 4385682061 | 1176 |
News Archive
U.S. hospitals can improve patient care and save at least $4 billion by being more efficient, according to Thomson Reuters, Reuters reports.
Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
A class action against the New South Wales (NSW) government over alleged radiation poisoning is being considered by the relatives of a number of Sydney residents who died of cancer in the 1970s.
› Verified 5 days ago
| Entity Name | Pace & Leatherwood, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912975277 PECOS PAC ID: 6901883776 Enrollment ID: O20040630000873 |
News Archive
U.S. hospitals can improve patient care and save at least $4 billion by being more efficient, according to Thomson Reuters, Reuters reports.
Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
A class action against the New South Wales (NSW) government over alleged radiation poisoning is being considered by the relatives of a number of Sydney residents who died of cancer in the 1970s.
› Verified 5 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20140522000040 |
News Archive
U.S. hospitals can improve patient care and save at least $4 billion by being more efficient, according to Thomson Reuters, Reuters reports.
Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
A class action against the New South Wales (NSW) government over alleged radiation poisoning is being considered by the relatives of a number of Sydney residents who died of cancer in the 1970s.
› Verified 5 days ago
| Entity Name | Privia Care Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164874426 PECOS PAC ID: 3274801139 Enrollment ID: O20170619000055 |
News Archive
U.S. hospitals can improve patient care and save at least $4 billion by being more efficient, according to Thomson Reuters, Reuters reports.
Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
A class action against the New South Wales (NSW) government over alleged radiation poisoning is being considered by the relatives of a number of Sydney residents who died of cancer in the 1970s.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Georgia Delarosa Cu, MD 11203 Old Ironside Ct, Fort Washington, MD 20744-4261 Ph: (301) 203-3388 | Dr Georgia Delarosa Cu, MD 12070 Old Line Ctr, Suite 302, Waldorf, MD 20602-2513 Ph: (301) 645-6667 |
News Archive
U.S. hospitals can improve patient care and save at least $4 billion by being more efficient, according to Thomson Reuters, Reuters reports.
Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
A class action against the New South Wales (NSW) government over alleged radiation poisoning is being considered by the relatives of a number of Sydney residents who died of cancer in the 1970s.
› Verified 5 days ago
Stacy O. Ross, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2855 Crain Hwy, Waldorf, MD 20601 Phone: 240-427-1926 Fax: 240-427-1927 | |
Ivy Wicks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12070 Old Line Ctr Ste 302, Waldorf, MD 20602 Phone: 301-645-6667 Fax: 301-870-9722 | |
Ashley Dunn-kerr, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3225 Crain Hwy, Waldorf, MD 20603 Phone: 301-638-7350 Fax: 301-645-6304 | |
Lachrisa S. Jennings, D.O Family Medicine Medicare: Medicare Enrolled Practice Location: 2855 Crain Hwy, Waldorf, MD 20601 Phone: 240-427-1926 | |
Dainty J Jackson, D. O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11315 Pembrooke Sq Ste 112, Waldorf, MD 20603 Phone: 301-885-3350 Fax: 240-222-3899 | |
Robert Timothy Pace, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12070 Old Line Ctr, Suite 302, Waldorf, MD 20602 Phone: 301-645-6667 Fax: 301-870-9722 | |
Nauras Hwig, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3581 Old Washington Rd Ste E, Waldorf, MD 20602 Phone: 301-638-5500 |